15018 Federal Register / Vol. 80, No. 54 / Friday, March 20, 2015 / Notices 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, Clinical 

Coordination Center (2243). 

Date: April 21, 2015. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Lyle Furr, Scientific 

Review Officer, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 4227, MSC 9550, 6001 

Executive Boulevard, Bethesda, MD 20892– 

9550, (301) 435–1439, lf33c.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No.: 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: March 13, 2015. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–06348 Filed 3–19–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIH Support for 

Conferences and Scientific Meeting (R13/

U13). 

Date: April 13–15, 2015. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Room 

3F30B, 5601 Fishers Lane, Rockville, MD 

20852 (Virtual Meeting). 

Contact Person: Jane K. Battles, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID, 5601 

Fishers Lane, Room 3F30B, Rockville, MD 

20852, 240–669–5029, battlesja@

mail.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Clinical Trial 

Planning Grants (R34). 

Date: April 16, 2015. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Room 

2H200B, 5601 Fisher Lane, Rockville, MD 

20892 (Telephone Conference Call). 

Contact Person: Jane K. Battles, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID 5601 

Fishers Lane, Room 3F30B, Rockville, MD 

20852, 240–669–5029, battlesja@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: March 13, 2015. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–06347 Filed 3–19–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–1936] 

Electronic Cigarettes and the Public 

Health; Public Workshop 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop; 

extension of comment period. 

The Food and Drug Administration 

(FDA), Center for Tobacco Products, is 

announcing a public workshop to obtain 

information on electronic cigarettes (ecigarettes) and the public health. This 

will be the final in a series of three 

workshops. The workshop will include 

presentations and panel discussions 

about the current state of the science 

and will focus on impacts on the 

population as a whole, including users 

and non-users of tobacco products. 

Dates and Times: The public 

workshop will be held on June 1 and 2, 

2015. Individuals who wish to attend 

the public workshop must register by 

May 20, 2015. 

Location: The public workshop will 

be held at the Marriott Inn and 

Conference Center, University of 

Maryland University College, Potomac 

Ballroom, 3501 University Blvd. East, 

Hyattsville, MD 20783. The conference 

center’s telephone number is 301–985– 

7300. 

Contact Person: Caryn Cohen, Office 

of Science, Center for Tobacco Products, 

Food and Drug Administration, 

Document Control Center, 10903 New 

Hampshire Ave., Bldg. 71, Rm. G335, 

Silver Spring, MD 20993–0002, 1–877– 

287–1373, email: workshop.CTPOS@

fda.hhs.gov. 

Registration to Attend the Workshop: 

If you wish to attend the workshop in 

person or by Webcast, you must register 

by submitting an electronic or written 

request no later than May 20, 2015. 

Please submit electronic requests at 

https://www.surveymonkey.com/s/CTPJune-Workshop. Persons without 

Internet access may send written 

requests for registration to Caryn Cohen 

(see Contact Person). Requests for 

registration must include the 

prospective attendee’s name, title, 

affiliation, address, email address if 

available, and telephone number. 

Registration is free and you may register 

to attend in-person or view the live 

Webcast. Seating and viewership are 

limited, so early registration is 

recommended. FDA may limit the 

number of registrants from a single 

organization and the total number of 

participants if registration reaches full 

capacity. For registrants with Internet 

access, confirmation of registration will 

be emailed to you no later than May 25, 

2015. Onsite registration may be 

allowed if space is available. If 

registration reaches maximum capacity, 

FDA will post a notice closing 

registration at http://www.fda.gov/

TobaccoProducts/NewsEvents/

ucm238308.htm. 

If you need special accommodations 

due to a disability, please contact Caryn 

Cohen (see Contact Person) at least 7 

days in advance of the meeting. 

Presenters and Panelists: FDA is 

interested in gathering scientific 

information from individuals with a 

broad range of backgrounds on the 

scientific topics to be discussed at the 

workshop. To be considered as a 

presenter, please provide the following: 

• A brief abstract for each 

presentation. The abstract should 

identify the specific topic(s) to be 

addressed and the amount of time 

requested. 

• A one-page biosketch that describes 

and supports the speaker’s scientific 

expertise on the specific topic(s) being 

presented, nature of the individual’s 

experience and research in the scientific 

field, positions held, and any program 

development activities. 

Panelists will discuss their scientific 

knowledge on the questions and 

mstockstill on DSK4VPTVN1PROD with NOTICES